Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000891839-20-000118
Filing Date
2020-05-18
Accepted
2020-05-18 16:19:37
Documents
1
Period of Report
2020-05-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 6794
  Complete submission text file 0000891839-20-000118.txt   8201
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Issuer) CIK: 0001205922 (see all company filings)

EIN.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1018 W. 8TH AVENUE SUITE A KING OF PRUSSIA PA 19406
Business Address
Yanni Barbara (Reporting) CIK: 0001610561 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38624 | Film No.: 20889768